BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Farmers Insurance
McKesson
McKinsey
Covington
Federal Trade Commission
Express Scripts
UBS
Deloitte

Generated: January 20, 2018

DrugPatentWatch Database Preview

NALOXONE Drug Profile

« Back to Dashboard

When do Naloxone patents expire, and what generic alternatives are available?

Naloxone is a drug marketed by West-ward Pharms Int, Wyeth Ayerst, Abraxis Pharm, Akorn, Astrazeneca, Eurohlth Intl Sarl, Hospira, Igi Labs Inc, Intl Medication, Marsam Pharms Llc, Mylan Institutional, Smith And Nephew, Solopak, Somerset Theraps Llc, Watson Labs, Gavis Pharms, and Sun Pharm Inds Ltd. and is included in fifty-six NDAs.

The generic ingredient in NALOXONE is naloxone hydrochloride; pentazocine hydrochloride. There are twelve drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride; pentazocine hydrochloride profile page.
Drug patent expirations by year for NALOXONE
Pharmacology for NALOXONE
Drug ClassOpioid Antagonist
Mechanism of ActionOpioid Antagonists

US Patents and Regulatory Information for NALOXONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Intl Medication NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 072076-001 Mar 24, 1988 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Igi Labs Inc NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 072087-001 Apr 11, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Solopak NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 071672-001 Nov 17, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Institutional NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 205014-001 Jun 29, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Solopak NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 071683-001 Nov 17, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Ltd NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE naloxone hydrochloride; pentazocine hydrochloride TABLET;ORAL 075523-001 Mar 17, 2000 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Igi Labs Inc NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 072083-001 Apr 11, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Igi Labs Inc NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 072088-001 Apr 11, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Igi Labs Inc NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 072084-001 Apr 11, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int NALOXONE naloxone hydrochloride INJECTABLE;INJECTION 070298-001 Sep 24, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Deloitte
US Department of Justice
Fuji
Express Scripts
Moodys
Colorcon
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot